answer text |
<p>British Patient Capital (BPC) was created in 2018 following the Patient Capital
Review, and allocated £2.5 billion to invest over the ten years to 2028/29. In July
2021, it was allocated a further £375m to deliver the Future Fund: Breakthrough programme
and £200m to deliver the Life Sciences Investment Programme (LSIP). As at 31 March
2022, total value of all commitments and co-investments reached £1.6bn across 61 fund
commitments, four co-investments from BPC’s Core programme, and five Future Fund:
Breakthrough deals. At Spring Budget 2023, BPC’s mandate was extended until 2033/34.</p>
|
|